EnteroMedics Inc (ETRM)

5.06
0.01 0.20
NASDAQ : Health Care
Prev Close 5.05
Open 5.01
Day Low/High 4.84 / 5.28
52 Wk Low/High 0.20 / 5.85
Volume 329.11K
Avg Volume 568.50K
Exchange NASDAQ
Shares Outstanding 6.91M
Market Cap 34.40M
EPS -37.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

EnteroMedics Announces The Acquisition Of The Gastric Vest System

- At 12 Months, Gastric Vest System™ Patients Demonstrated Excess Weight Loss (EWL) of 85% and Waist Circumference Reduction of 38 Centimeters -

EnteroMedics' VBloc® Neurometabolic Therapy Featured On "The Doctors" TV Show

Segment Featuring vBloc Institute Surgeon Dr. Frank Chae and patient Cindy Hudak Airs March 14

EnteroMedics Regains Compliance With Nasdaq Listing Requirement

- Company to Host Fourth Quarter 2016 Financial Results and Commercial Update Conference Call on Tuesday, March 7, 2017 at 11:00 AM ET -

EnteroMedics Announces Publication Of Three-Year Data From VBloc Diabetic Patient Study In Journal Of Diabetes And Obesity

vBloc® Therapy Demonstrates Significant and Sustained Weight Loss and Glycemic Control in Obese Patients with Type 2 Diabetes

Still Struggling to Put Money to Work

Still Struggling to Put Money to Work

Breadth has improved quite a bit, but it is a challenge to find new inventory.

This Small-Cap Rotation Is Unconvincing

This Small-Cap Rotation Is Unconvincing

Traders, pressed to find some action, are chasing certain things to a ridiculous extent.

Bullish and Bearish Reversals in the Market

Bullish and Bearish Reversals in the Market

These companies show signs of a change of direction.

Stock Picks Are Hard to Find as Small-Caps Struggle

Stock Picks Are Hard to Find as Small-Caps Struggle

With poor breadth and money managers hiding in large-caps, I am being cautious, right now.

These 5 Stocks Under $10 Could Make You a Lot of Money

These 5 Stocks Under $10 Could Make You a Lot of Money

Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.

EnteroMedics Announces Retirement Of All Senior Convertible Notes

EnteroMedics Announces Retirement Of All Senior Convertible Notes

Key Element of Plan to Regain Nasdaq Listing Compliance

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

TheStreet's biotech columnist offers his own report card on biotech stocks.

Commercial Patient Data Confirms Success Of EnteroMedics' VBloc® Therapy In Combination With VBloc® Achieve Program In Patients Struggling To Lose Weight

Commercial Patient Data Confirms Success Of EnteroMedics' VBloc® Therapy In Combination With VBloc® Achieve Program In Patients Struggling To Lose Weight

vBloc Institute Data Corroborates Pivotal Clinical Trial Results at Six and Nine Months

EnteroMedics To Host VBloc® Therapy Commercialization And Corporate Update Conference Call

EnteroMedics To Host VBloc® Therapy Commercialization And Corporate Update Conference Call

- Company to hold conference call today at 11:00 AM Eastern Time -

EnteroMedics Provides Commercialization And Corporate Update

EnteroMedics Provides Commercialization And Corporate Update

- Company to hold conference call November 30, 2016 at 11:00 AM Eastern Time -

Live Rescue Surgery Implanting VBloc® For Failed Gastric Sleeve To Be Broadcast At ObesityWeek 2016 Conference

Live Rescue Surgery Implanting VBloc® For Failed Gastric Sleeve To Be Broadcast At ObesityWeek 2016 Conference

EnteroMedics' Chief Medical Officer to Co-Moderate Neuromodulation Panel